

Brazil is one of many governments working to strike a balance between public and private interests in determining how medical innovation is conducted and incentivised – and how medical products and technologies can be made accessible for the benefit of public health.
At this point, several bills and recommendations have been tabled in the Brazilian Congress.
Approval of these would both insure the patent law is better suited to answer public health needs, and enable Brazil to play a leading global role in addressing the fundamental flaws in medical research.
The time to act is now.